Kender Richard N
SEC-identified person · CIK 1381205 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Seres Therapeutics, Inc. MCRB | Director · See Remarks | filed 2015 - 2026 |
| Longeveron Inc. LGVN | Director | filed 2024 - 2025 |
| Bicycle Therapeutics plc BCYC | Director | filed 2019 - 2025 |
| Omega Therapeutics, Inc. OMGA | Director | filed 2024 - 2024 |
| Syneos Health, Inc. SYNH | Director | filed 2014 - 2017 |
| Foxhollow Technologies, INC. FOXH | Director | filed 2006 - 2007 |
| ev3 Inc. evvvv | Director | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.